Wiernik P H
Clin Haematol. 1978 Jun;7(2):259-73. doi: 10.1016/s0308-2261(78)80005-8.
Although progress in the treatment of adult acute leukaemia has been much less dramatic than that which has occurred in the management of children with ALL, it should be clear from this progress report that significant strides have recently been made in the treatment of both adult ANLL and ALL that are of real benefit to the individual patient. This improvement is equally the result of improved supportive care and antileukaemia treatment. The progress has been of sufficient magnitude to clearly justify the optimism expressed in several recent reviews of leukaemia treatment (Freireich et al, 1976; Holland et al, 1976; Wiernik, 1976).
尽管成人急性白血病的治疗进展远不如儿童急性淋巴细胞白血病（ALL）的治疗那样显著，但从这份进展报告中可以清楚地看出，成人急性非淋巴细胞白血病（ANLL）和ALL的治疗最近都取得了重大进展，这对个体患者具有实际益处。这种改善同样得益于支持治疗和抗白血病治疗的改进。进展幅度之大足以明确证明近期几篇白血病治疗综述（Freireich等人，1976年；Holland等人，1976年；Wiernik，1976年）中所表达的乐观态度是合理的。
